Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation
Abstract
Inosine monophosphate dehydrogenase (IMPDH) mediates the first committed step in guanine nucleotide biosynthesis and plays important roles in cellular proliferation and the immune response. IMPDH reversibly polymerizes in cells and tissues in response to changes in metabolic demand. Self-assembly of metabolic enzymes is increasingly recognized as a general mechanism for regulating activity, typically by stabilizing specific conformations of an enzyme, but the regulatory role of IMPDH filaments has remained unclear. Here, we report a series of human IMPDH2 cryo-EM structures in both active and inactive conformations. The structures define the mechanism of filament assembly, and reveal how filament-dependent allosteric regulation of IMPDH2 makes the enzyme less sensitive to feedback inhibition, explaining why assembly occurs under physiological conditions that require expansion of guanine nucleotide pools. Tuning sensitivity to an allosteric inhibitor distinguishes IMPDH from other metabolic filaments, and highlights the diversity of regulatory outcomes that can emerge from self-assembly.
Data availability
The cryo-EM maps described here have been deposited in the Electron Microscopy Data Bank with accession numbers 20687, 20688, 20690, 20691, 20701, 20704, 20705, 20706, 20707, 20709, 20716, 20718, 20720, 20722, 20723, 20725, 20742, 20741, and 20743. The refined atomic coordinates have been deposited in the Protein Data Bank with accession numbers 6U8E, 6U8N, 6U8R, 6U8S, 6U9O, 6UA2, 6UA4, 6UA5, 6UAJ, 6UC2, 6UDP, 6UDO, and 6UDQ.
-
IMPDH2 ATP, IMP, NAD+ assembly interface cryo-EM mapElectron Microscopy Data Bank, 20687.
-
IMPDH2 ATP, IMP, NAD+ assembly interface atomic modelProtein Data Bank, 6U8E.
-
IMPDH2 ATP, IMP, NAD+ fully extended cryo-EM mapElectron Microscopy Data Bank, 20688.
-
IMPDH2 ATP, IMP, NAD+ fully extended atomic modelProtein Data Bank, 6U8N.
-
IMPDH2 ATP, IMP, NAD+ Bent (1:3) cryo-EM mapElectron Microscopy Data Bank, 20690.
-
IMPDH2 ATP, IMP, NAD+ Bent (1:3) atomic modelProtein Data Bank, 6U8R.
-
IMPDH2 ATP, NAD+ assembly interface cryo-EM mapElectron Microscopy Data Bank, 20718.
-
IMPDH2 ATP, NAD+ fully extended cryo-EM mapElectron Microscopy Data Bank, 20716.
-
IMPDH2 ATP, NAD+ fully compressed cryo-EM mapElectron Microscopy Data Bank, 20709.
-
IMPDH2 ATP, IMP assembly interface cryo-EM mapElectron Microscopy Data Bank, 20723.
-
IMPDH2 ATP, IMP fully extended cryo-EM mapElectron Microscopy Data Bank, 20722.
-
IMPDH2 ATP, IMP fully compressed cryo-EM mapElectron Microscopy Data Bank, 20720.
-
IMPDH2 ATP, GTP free octamerElectron Microscopy Data Bank, 20725.
-
IMPDH2 ATP, GTP, IMP assembly interfaceElectron Microscopy Data Bank, 20742.
-
IMPDH2 ATP, GTP, IMP assembly interfaceProtein Data Bank, 6UDP.
-
IMPDH2 ATP, GTP, IMP fully compressedElectron Microscopy Data Bank, 20741.
-
IMPDH2 ATP, GTP, IMP fully compressedProtein Data Bank, 6UDO.
-
IMPDH2 ATP, GTP, IMP fully compressed endElectron Microscopy Data Bank, 20743.
-
IMPDH2 ATP, GTP, IMP fully compressed endProtein Data Bank, 6UDQ.
-
IMPDH2 ATP, GTP, IMP, NAD+ assembly interface cryo-EM mapElectron Microscopy Data Bank, 20691.
-
IMPDH2 ATP, GTP, IMP, NAD+ assembly interface atomic modelProtein Data Bank, 6U8S.
-
IMPDH2 ATP, GTP, IMP, NAD+ bent (2:2) cryo-EM mapElectron Microscopy Data Bank, 20704.
-
IMPDH2 ATP, GTP, IMP, NAD+ bent (2:2) atomic modelProtein Data Bank, 6UA2.
-
IMPDH2 ATP, GTP, IMP, NAD+ bent (3:1) cryo-EM mapElectron Microscopy Data Bank, 20705.
-
IMPDH2 ATP, GTP, IMP, NAD+ bent (3:1) atomic modelProtein Data Bank, 6UA4.
-
IMPDH2 ATP, GTP, IMP, NAD+ fully compressed cryo-EM mapElectron Microscopy Data Bank, 20701.
-
IMPDH2 ATP, GTP, IMP, NAD+ fully compressed atomic modelProtein Data Bank, 6U9O.
-
IMPDH2 ATP, GTP, IMP, NAD+ free octamer cryo-EM mapElectron Microscopy Data Bank, 20707.
-
IMPDH2 ATP, GTP, IMP, NAD+ free octamer atomic modelProtein Data Bank, 6UAJ.
-
IMPDH2 ATP, GTP, IMP, NAD+ free interfacial octamer cryo-EM mapElectron Microscopy Data Bank, 20706.
Article and author information
Author details
Funding
National Institutes of Health (5R01GM118396-04)
- Justin M Kollman
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2020, Johnson & Kollman
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,822
- views
-
- 641
- downloads
-
- 74
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Structural Biology and Molecular Biophysics
Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.
-
- Structural Biology and Molecular Biophysics
SCARF1 (scavenger receptor class F member 1, SREC-1 or SR-F1) is a type I transmembrane protein that recognizes multiple endogenous and exogenous ligands such as modified low-density lipoproteins (LDLs) and is important for maintaining homeostasis and immunity. But the structural information and the mechanisms of ligand recognition of SCARF1 are largely unavailable. Here, we solve the crystal structures of the N-terminal fragments of human SCARF1, which show that SCARF1 forms homodimers and its epidermal growth factor (EGF)-like domains adopt a long-curved conformation. Then, we examine the interactions of SCARF1 with lipoproteins and are able to identify a region on SCARF1 for recognizing modified LDLs. The mutagenesis data show that the positively charged residues in the region are crucial for the interaction of SCARF1 with modified LDLs, which is confirmed by making chimeric molecules of SCARF1 and SCARF2. In addition, teichoic acids, a cell wall polymer expressed on the surface of gram-positive bacteria, are able to inhibit the interactions of modified LDLs with SCARF1, suggesting the ligand binding sites of SCARF1 might be shared for some of its scavenging targets. Overall, these results provide mechanistic insights into SCARF1 and its interactions with the ligands, which are important for understanding its physiological roles in homeostasis and the related diseases.